AND EXCHANGE COMMISSION
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
of Report (Date of earliest event reported): January 9, 2013
JUDE MEDICAL, INC.
name of registrant as specified in its charter)
(State or other jurisdiction
One St. Jude Medical Drive, St. Paul, MN
(Address of principal executive offices)
telephone number, including area code: (651) 756-2000
name or former address, if changed since last report)
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
2.02 Results of Operations and Financial Condition.
January 9, 2013, St. Jude Medical, Inc. issued a press release concerning its preliminary financial results for the fourth quarter
2012. A copy of the press release is furnished as Exhibit 99.1 to this report.
9.01 Financial Statements and Exhibits.
Press release issued by St. Jude Medical, Inc. on January 9, 2013.
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
||ST. JUDE MEDICAL, INC.|
|Date: January 9, 2013
||/s/ Jason Zellers|
Vice President, General Counsel
and Corporate Secretary
||Description of Exhibit|
||Press release issued by St. Jude Medical, Inc. on January 9, 2013.|